NCT01613131 Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression Status COMPLETED Phase NA
NCT01613105 Diabetes Treatment With Glucobay in Combination With Sulfonylurea Status COMPLETED Phase N/A
NCT01612741 Diabetes Treatment With Glucobay in Combination With Metformin Status COMPLETED Phase N/A
NCT01608867 A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT01606995 Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation Status COMPLETED Phase N/A
NCT01602770 Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy Status COMPLETED Phase N/A
NCT01595724 Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life Status COMPLETED Phase N/A
NCT01592149 Survey of Prevalence of Loss of Appetite in Subject With Health Disorders Status COMPLETED Phase N/A
NCT01590537 Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction Status COMPLETED Phase N/A
NCT01588639 To Evaluate Clinical Outcome and Injection Compliance of Scilin Status COMPLETED Phase N/A
NCT01588106 Evaluation of CONTOUR® USB BGMS on Glycaemic Control in Insulin-treated Diabetic Patients Status COMPLETED Phase N/A
NCT01587885 Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036) Status COMPLETED Phase PHASE4
NCT01585974 Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT01585870 Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination Status COMPLETED Phase PHASE1
NCT01584830 Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy Status COMPLETED Phase PHASE3
NCT01580293 A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A Status COMPLETED Phase PHASE2/PHASE3
NCT01573338 Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer) Status TERMINATED Phase PHASE1/PHASE2